Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 0 0.000% |
-2,458,958 (Position Closed) |
Filing History |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,458,958 6.500% |
-293,237 (-10.65%) |
Filing History |
| 2024-02-14 4:00 pm Purchase |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
TANG CAPITAL PARTNERS LP | 3,652,244 9.600% |
919,994 (+33.67%) |
Filing History |
| 2024-02-13 5:00 pm Sale |
2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,073,005 5.500% |
-200,000 (-8.80%) |
Filing History |
| 2024-02-12 9:41 pm Unchanged |
2024-02-12 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.100% |
0 (Unchanged) |
Filing History |
| 2023-04-20 4:13 pm Purchase |
2023-04-10 | 13G | Bolt Biotherapeutics, Inc. BOLT |
TANG CAPITAL PARTNERS LP | 2,732,250 7.200% |
2,732,250 (New Position) |
Filing History |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,752,195 7.300% |
-60,254 (-2.14%) |
Filing History |
| 2023-02-13 12:36 pm Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-2,230,250 (Position Closed) |
Filing History |
| 2023-01-04 4:20 pm Sale |
2022-12-29 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 0 0.000% |
-2,534,465 (Position Closed) |
Filing History |
| 2022-12-28 2:51 pm Sale |
2022-12-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 2,534,465 6.700% |
-1,169,526 (-31.57%) |
Filing History |
| 2022-09-30 4:48 pm Unchanged |
2022-09-27 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 3,703,991 9.800% |
0 (Unchanged) |
Filing History |
| 2022-07-15 4:01 pm Sale |
2022-07-13 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 3,703,991 9.800% |
-800,000 (-17.76%) |
Filing History |
| 2022-05-16 4:31 pm Sale |
2022-05-16 | 13G | Bolt Biotherapeutics, Inc. BOLT |
RA Capital Management, L.P. | 0 0.000% |
-2,378,325 (Position Closed) |
Filing History |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,812,449 7.500% |
-129,558 (-4.40%) |
Filing History |
| 2021-11-29 4:39 pm Purchase |
2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,230,250 6.000% |
2,230,250 (New Position) |
Filing History |
| 2021-11-22 4:03 pm Unchanged |
2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 4,503,991 12.000% |
0 (Unchanged) |
Filing History |
| 2021-08-13 5:02 pm Purchase |
2021-02-21 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.400% |
1,166,952 (+61.70%) |
Filing History |
| 2021-04-07 4:30 pm Purchase |
2021-04-01 | 13G | Bolt Biotherapeutics, Inc. BOLT |
RA Capital Management, L.P. | 2,378,325 6.500% |
2,378,325 (New Position) |
Filing History |
| 2021-02-19 4:03 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,942,007 8.100% |
2,942,007 (New Position) |
Filing History |
| 2021-02-18 4:50 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Vivo Capital VIII LLC | 2,273,005 6.600% |
2,273,005 (New Position) |
Filing History |